Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells. Xia L, Liu JY, Yang MY, Zhang XH, et al. Cancer Res 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xia L, Liu JY, Yang MY, Zhang XH, et al. Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells. Cancer Res 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.
PMID: 38095536